Michael John Tomsicek, Director at Milestone Pharmaceuticals Inc. (MIST), bought 15,000 shares at $5.32 ($80K) on 2022-10-19, disclosed to the SEC on 2022-10-21.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| Filing → |
| CRSP | SELL | 2020-08-05 | $1.5M | — | Filing → |
| CBST | SELL | 2014-08-18 | $26K | — | Filing → |
| CBST | SELL | 2014-05-14 | $34K | — | Filing → |